These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 10348284)

  • 1. The optimal dose of radiation in Hodgkin's disease: an analysis of clinical and treatment factors affecting in-field disease control.
    Mendenhall NP; Rodrigue LL; Moore-Higgs GJ; Marcus RB; Million RR
    Int J Radiat Oncol Biol Phys; 1999 Jun; 44(3):551-61. PubMed ID: 10348284
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of radiotherapy dose and other treatment-related and clinical factors on in-field control in stage I and II non-Hodgkin's lymphoma.
    Kamath SS; Marcus RB; Lynch JW; Mendenhall NP
    Int J Radiat Oncol Biol Phys; 1999 Jun; 44(3):563-8. PubMed ID: 10348285
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is combined modality therapy necessary for advanced Hodgkin's disease?
    Mendenhall NP; Bennett CJ; Lynch JW
    Int J Radiat Oncol Biol Phys; 1997 Jun; 38(3):583-92. PubMed ID: 9231683
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does bulky disease at diagnosis influence outcome in childhood Hodgkin's disease and require higher radiation doses? Results from the German-Austrian Pediatric Multicenter Trial DAL-HD-90.
    Dieckmann K; Pötter R; Hofmann J; Heinzl H; Wagner W; Schellong G;
    Int J Radiat Oncol Biol Phys; 2003 Jul; 56(3):644-52. PubMed ID: 12788169
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiation dose selection in Hodgkin's disease patients with large mediastinal adenopathy treated with combined modality therapy.
    Elconin JH; Roberts KB; Rizzieri DA; Vermont C; Clough RW; Kim C; Dodge RK; Prosnitz LR
    Int J Radiat Oncol Biol Phys; 2000 Nov; 48(4):1097-105. PubMed ID: 11072168
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improved survival in patients with limited stage IIIA Hodgkin's disease treated with combined radiation therapy and chemotherapy.
    Marcus KC; Kalish LA; Coleman CN; Shulman LN; Rosenthal DS; Canellos GP; Mauch PM
    J Clin Oncol; 1994 Dec; 12(12):2567-72. PubMed ID: 7989930
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of in-field control and late toxicity for adults with early-stage Hodgkin's disease treated with chemotherapy followed by radiotherapy.
    Chronowski GM; Wilder RB; Tucker SL; Ha CS; Younes A; Fayad L; Rodriguez MA; Hagemeister FB; Barista I; Cabanillas F; Cox JD
    Int J Radiat Oncol Biol Phys; 2003 Jan; 55(1):36-43. PubMed ID: 12504034
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stage IA-IIB Hodgkin's disease: management and outcome of extensive thoracic involvement.
    Hughes-Davies L; Tarbell NJ; Coleman CN; Silver B; Shulman LN; Linggood R; Canellos GP; Mauch PM
    Int J Radiat Oncol Biol Phys; 1997 Sep; 39(2):361-9. PubMed ID: 9308940
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term follow-up of patients treated with primary radiotherapy for supradiaphragmatic Hodgkin's disease at St. Jude Children's Research Hospital.
    Shah AB; Hudson MM; Poquette CA; Luo X; Wilimas JA; Kun LE
    Int J Radiat Oncol Biol Phys; 1999 Jul; 44(4):867-77. PubMed ID: 10386644
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced treatment intensity in patients with early-stage Hodgkin's lymphoma.
    Engert A; Plütschow A; Eich HT; Lohri A; Dörken B; Borchmann P; Berger B; Greil R; Willborn KC; Wilhelm M; Debus J; Eble MJ; Sökler M; Ho A; Rank A; Ganser A; Trümper L; Bokemeyer C; Kirchner H; Schubert J; Král Z; Fuchs M; Müller-Hermelink HK; Müller RP; Diehl V
    N Engl J Med; 2010 Aug; 363(7):640-52. PubMed ID: 20818855
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined-modality therapy versus radiotherapy alone for treatment of early-stage Hodgkin's disease: cure balanced against complications.
    Koontz BF; Kirkpatrick JP; Clough RW; Prosnitz RG; Gockerman JP; Moore JO; Prosnitz LR
    J Clin Oncol; 2006 Feb; 24(4):605-11. PubMed ID: 16446333
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dose-response relationship of complementary radiotherapy following four cycles of combination chemotherapy in intermediate-stage Hodgkin's disease.
    Loeffler M; Diehl V; Pfreundschuh M; Rühl U; Hasenclever D; Nisters-Backes H; Sieber M; Tesch H; Franklin J; Geilen W; Bartels H; Cartoni C; Dölken G; Enzian J; Fuchs R; Gassmann W; Gerhartz H; Hagen-Aukamp U; Hiller E; Hinkelbein H; Hinterberger W; Kirchner H; Koch P; Krüger B; Schwarze EW
    J Clin Oncol; 1997 Jun; 15(6):2275-87. PubMed ID: 9196141
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stage I-III Hodgkin's disease: outcome and pattern of failure following treatment with radiation therapy and chemotherapy in a modern era.
    Zapatero A; López MA; Cerezo L; De Vidales CM; MarIn A; Pérez-Torrubia A
    Hematology; 2002 Feb; 7(1):43-50. PubMed ID: 12171776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Subdiaphragmatic stage I & II Hodgkin's disease: long-term follow-up and prognostic factors.
    Liao Z; Ha CS; Fuller LM; Hagemeister FB; Cabanillas F; Tucker SL; Hess MA; Cox JD
    Int J Radiat Oncol Biol Phys; 1998 Jul; 41(5):1047-56. PubMed ID: 9719114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analyses of patterns-of-failure and prognostic factors according to radiation fields in early-stage Hodgkin lymphoma.
    Krebs L; Amorin S; Brice P; Guillerm S; Menard J; Hennequin C; Quéro L
    Strahlenther Onkol; 2017 Feb; 193(2):116-124. PubMed ID: 27316376
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Combined-modality therapy for 150 cases of early-stage Hodgkin's lymphoma].
    Niu Y; Shi YK; He XH; Feng FY; Zhou LQ; Gu DZ
    Zhonghua Zhong Liu Za Zhi; 2008 Aug; 30(8):630-4. PubMed ID: 19102946
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prospective study of combined modality treatment or radiotherapy alone in the management of early-stage adult Hodgkin's disease.
    Yildiz F; Zengin N; Engin H; Güllü I; Barista I; Caglar M; Ozyar E; Cengiz M; Gürkaynak M; Zorlu F; Caner B; Atahan IL; Tekuzman G
    Int J Radiat Oncol Biol Phys; 2004 Nov; 60(3):839-46. PubMed ID: 15465201
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hodgkin's disease in elderly patients (> or =60): clinical outcome and treatment strategies.
    Kim HK; Silver B; Li S; Neuberg D; Mauch P
    Int J Radiat Oncol Biol Phys; 2003 Jun; 56(2):556-60. PubMed ID: 12738333
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mantle irradiation alone for pathologic stage I and II Hodgkin's disease: long-term follow-up and patterns of failure.
    Liao Z; Ha CS; Vlachaki MT; Hagemeister F; Cabanillas F; Hess M; Tucker S; Cox JD
    Int J Radiat Oncol Biol Phys; 2001 Jul; 50(4):971-7. PubMed ID: 11429225
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Subdiaphragmatic Hodgkin's disease: the University of Florida experience.
    Hull MC; Mendenhall NP; Colgan ME
    Int J Radiat Oncol Biol Phys; 2002 Jan; 52(1):161-6. PubMed ID: 11777634
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.